MBX Biosciences, Inc. Common Stock (MBX) vs Privia Health Group, Inc. (PRVA)

A side-by-side comparison of MBX Biosciences, Inc. Common Stock and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.71B
$56.87HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Privia Health Group, Inc. logo
PRVA
Privia Health Group, Inc.
$2.56B
$20.34HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT

Total return — MBX vs PRVA

growth of $100 · dividends reinvested · last 2y
MBX +147.5% (+57.3%/yr)PRVA +7.9% (+3.9%/yr)MBX compounded faster over this window
100200300Start $10020252026$248$108
MBX PRVA

MBX vs PRVA: by the numbers

  • •MBX is the larger company ($2.71B vs $2.56B market cap).
  • •PRVA is profitable (1.19% net margin) while MBX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricMBXPRVA
P/E ratioN/A93.78
Forward P/EN/A78.98
P/S ratioN/A1.09
P/B ratio6.610.00

Profitability

MetricMBXPRVA
Gross margin0.00%7.61%
Operating margin0.00%1.90%
Net margin0.00%1.19%
ROE-25.47%0.00%
ROIC-28.60%0.00%

Growth (annualized)

MetricMBXPRVA
Revenue CAGR (5Y)N/A22.35%
EPS CAGR (5Y)N/A-8.73%
Total return CAGR (5Y)N/A-1.30%

Frequently asked

Is MBX or PRVA more profitable?
PRVA runs the higher net margin — MBX at 0.00% versus PRVA at 1.19%.

Go deeper

Full MBX analysisFull PRVA analysisInteractive comparison tool

Dig into the metrics

Privia Health P/E ratioMBX Biosciences, Inc. Common Stock ROEPrivia Health ROEMBX Biosciences, Inc. Common Stock operating marginPrivia Health operating marginMBX Biosciences, Inc. Common Stock revenue growthPrivia Health revenue growthMBX Biosciences, Inc. Common Stock free cash flowPrivia Health free cash flow

MBX Biosciences, Inc. Common Stock & Privia Health appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.